Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 4/20 | 0.52 |
| ▸ | CA2 | P00918 | 4/20 | 0.52 |
| ▸ | CA7 | P43166 | 3/20 | 0.52 |
| ▸ | CA9 | Q16790 | 3/20 | 0.43 |
| ▸ | CA4 | P22748 | 2/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21306522 | 1.00 | CA1 (0.52) | CA1CA2CA7CA9CA4 | |
| E968 SCHEMBL3294477 | 0.88 | CA1 (0.46) | CA1CA2CA7CA9LMNA | |
| Ethylene Glycol SCHEMBL28198773 | 0.88 | CA1 (0.46) | CA1CA2CA7CA9CA4 | |
| SCHEMBL8373146 | 0.87 | CA1 (0.48) | CA1CA2CA7CA9CA4 | |
| SCHEMBL657952 | 0.87 | CA1 (0.48) | CA1CA2CA7CA9CA4 | |
| SCHEMBL3970966 | 0.87 | CA1 (0.48) | CA1CA2CA7CA9CA4 | |
| SCHEMBL11059349 | 0.87 | CA1 (0.48) | CA1CA2CA7CA9CA4 | |
| SCHEMBL17186 | 0.87 | CA1 (0.48) | CA1CA2CA7CA9CA4 | |
| SCHEMBL2863103 | 0.87 | CA1 (0.48) | CA1CA2CA7CA9CA4 | |
| SCHEMBL10587296 | 0.87 | CA1 (0.48) | CA1CA2CA7CA9CA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024142846-A1 | COSMETIC COMPOSITION | 株式会社 資生堂 | 2024-07-04 | — | — | WO | disclosed |
| US-12004630-B2 | System for dispensing a cosmetic product | L'OREAL (FR) | 2024-06-11 | — | — | US | disclosed |
| US-11998104-B2 | System for dispensing a cosmetic product | L'OREAL (FR) | 2024-06-04 | — | — | US | disclosed |
| CN-114847615-B | System for dispensing cosmetics | 欧莱雅 | 2024-05-24 | — | — | CN | disclosed |
| US-11980277-B2 | System for dispensing a cosmetic product | L'OREAL (FR) | 2024-05-14 | — | — | US | disclosed |
| US-11974651-B2 | System for dispensing a cosmetic product | L'OREAL (FR) | 2024-05-07 | — | — | US | disclosed |
| CN-114847616-A | System for dispensing a cosmetic product | 欧莱雅 | 2022-08-05 | — | — | CN | disclosed |
| CN-114847615-A | System for dispensing a cosmetic product | 欧莱雅 | 2022-08-05 | — | — | CN | disclosed |
| CN-114847617-A | System for dispensing a cosmetic product | 欧莱雅 | 2022-08-05 | — | — | CN | disclosed |
| CN-114711533-A | System for dispensing a cosmetic product | 欧莱雅 | 2022-07-08 | — | — | CN | disclosed |
| EP-1741726-A1 | Curable aqueous composition and use as water repellant fiberglass nonwoven binder | Rohm and Haas France SAS (FR) | 2007-01-10 | — | — | EP | disclosed |
| EP-1741763-A1 | Curable compositions comprising reactive beta-hydroxyamides from lactones | Rohm and Haas Company (US) | 2007-01-10 | — | — | EP | disclosed |
| EP-1506977-B1 | Curable composition and use as binder | ROHM & HAAS (US) | 2006-12-27 | — | — | EP | disclosed |
| US-20060127674-A1 | Curable composition and use as binder | BLANKENSHIP ROBERT M | 2006-06-15 | — | — | US | disclosed |
| US-20050214534-A1 | Extended curable compositions for use as binders | ADAMO JOSEPH R | 2005-09-29 | — | — | US | disclosed |
| EP-1580199-A1 | Curable composition and use thereof | ROHM AND HAAS COMPANY (US) | 2005-09-28 | — | — | EP | disclosed |
| EP-1506977-A1 | Curable composition and use as binder | ROHM AND HAAS COMPANY (US) | 2005-02-16 | — | — | EP | disclosed |
| EP-0774506-B1 | High alkali-containing cleaning concentrates | ROHM & HAAS (US) | 2003-04-02 | — | — | EP | disclosed |
| US-5770555-A | WATER SOLUBLE POLYMER | ROHM AND HAAS COMPANY (US) | 1998-06-23 | — | — | US | disclosed |
| EP-0774506-A2 | High alkali-containing cleaning concentrates | ROHM AND HAAS COMPANY (US) | 1997-05-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11980277-B2 | System for dispensing a cosmetic product | PDE12, SAMM50, POLR1C | CA1 4676/4885CA2 2441/4885CA7 2795/4885 |
| US-11974651-B2 | System for dispensing a cosmetic product | PDE12, SAMM50, POLR1C | CA1 4676/4885CA2 2441/4885CA7 2795/4885 |
| US-11998104-B2 | System for dispensing a cosmetic product | PDE12, SAMM50, POLR1C | CA1 4676/4885CA2 2441/4885CA7 2795/4885 |
| US-12004630-B2 | System for dispensing a cosmetic product | PDE12, SAMM50, POLR1C | CA1 4676/4885CA2 2441/4885CA7 2795/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.